Tikvah Therapeutics to Present At Lazard Capital Markets Healthcare Conference On November 27

ATLANTA, Nov. 16, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc., an Atlanta, GA-based biopharmaceutical company focused on new treatment options to better manage central nervous system diseases, announced today that Dr. Harold H. Shlevin, president and chief executive officer of Tikvah, is scheduled to present at the Lazard Capital Markets Fourth Annual Healthcare Conference. The presentation will take place in New York on Tuesday, November 27, 2007, at 9:00 am EST.